90% of pharmaceuticals sold in the U.S. are generics. 80% are produced overseas, where FDA inspections are declining. Here's how carcinogens and other impurities end up in America's medicine supply

90% of pharmaceuticals sold in the U.S. are generics.

80% are produced overseas, where FDA inspections are declining.

Here's how carcinogens and other impurities end up in America's medicine supply https://t.co/H2DRmDckEN

— Bloomberg (@business) September 19, 2019